Netsol Technologies CEO Najeeb Ghauri buys $19,500 in stock ...

Fact: Thalassemia is passed from parents to their off-springs through the defective gene. It cannot spread to others through touch, sharing food or utensils, or through cough and cold. Myth: Only ...

Thalassemia continues to pose a serious public health challenge in India, with thousands of children dependent on lifelong blood transfusions and careful monitoring. While advances in screening and ...

In an exclusive interview with India Today, former Delhi Lieutenant Governor Najeeb Jung discusses the Public Interest Litigation (PIL) filed in the Supreme Court against alleged hate speech by ...

The FDA delivered a pair of holiday season approvals a week apart, signing off on Agios’ oral medicine Aqvesme for the treatment of anemia in adults with alpha- or beta-thalassemia on Dec. 23, and ...

Aqvesme is expected to be available in late January 2026. The Food and Drug Administration (FDA) has approved Aqvesme™ (mitapivat) for the treatment of anemia in adults with alpha- or beta-thalassemia ...

The U.S. Food and Drug Administration (FDA) on Tuesday approved Agios Pharmaceuticals, Inc.’s (NASDAQ: AGIO) Aqvesme (mitapivat), an oral pyruvate kinase (PK) activator, for anemia in adults with ...

What Is Aqvesme, and Why Does It Matter? Aqvesme (mitapivat) is a new oral medicine approved by the FDA for treating anemia in adults with alpha- or beta-thalassemia, including those who need and ...